| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on August 9, 2005
From the Departments of Anesthesia (L.X., X.N.T., Y.Q., R.G.G.) and Neurosurgery (R.G.G.), Stanford University School of Medicine, California; and Department of Neurology (M.A.Y., X.N.T.), University of California, San Francisco, and the San Francisco Veterans Affairs Medical Center, California. * To whom correspondence should be addressed. E-mail: yenari{at}alum.mit.edu.
Background--Blood-brain barrier (BBB) disruption after stroke can worsen ischemic injury by increasing edema and causing hemorrhage. We determined the effect of microglia on the BBB and its primary constituents, endothelial cells (ECs) and astrocytes, after ischemia using in vivo and in vitro models. Methods and Results--Primary astrocytes, ECs, or cocultures were prepared with or without added microglia. Primary ECs were more resistant to oxygen-glucose deprivation/reperfusion than astrocytes. ECs plus astrocytes showed intermediate vulnerability. Microglia added to cocultures nearly doubled cell death. This increase was prevented by minocycline and apocynin. In vivo, minocycline reduced infarct volume and neurological deficits and markedly reduced BBB disruption and hemorrhage in mice after experimental stroke. Conclusions--Inhibition of microglial activation may protect the brain after ischemic stroke by improving BBB viability and integrity. Microglial inhibitors may prove to be an important treatment adjunct to fibrinolysis.
Revised on September 29, 2005
Accepted on November 8, 2005
Microglia Potentiate Damage to Blood-Brain Barrier Constituents. Improvement by Minocycline In Vivo and In Vitro
Midori A. Yenari MD*;
This article has been cited by other articles:
![]() |
G. S. Kim, J. E. Jung, K. Niizuma, and P. H. Chan CK2 Is a Novel Negative Regulator of NADPH Oxidase and a Neuroprotectant in Mice after Cerebral Ischemia J. Neurosci., November 25, 2009; 29(47): 14779 - 14789. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Drabek, S. A. Tisherman, L. Beuke, J. Stezoski, K. Janesko-Feldman, M. Lahoud-Rahme, and P. M. Kochanek Deep Hypothermia Attenuates Microglial Proliferation Independent of Neuronal Death After Prolonged Cardiac Arrest in Rats Anesth. Analg., September 1, 2009; 109(3): 914 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Machado, I. Y. Sazonova, A. Kozak, D. C. Wiley, A. B. El-Remessy, A. Ergul, D. C. Hess, J. L. Waller, and S. C. Fagan Minocycline and Tissue-Type Plasminogen Activator for Stroke: Assessment of Interaction Potential Stroke, September 1, 2009; 40(9): 3028 - 3033. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. N. Tang, Q. Wang, M. A. Koike, D. Cheng, M. L. Goris, F. G. Blankenberg, and M. A. Yenari Monitoring the Protective Effects of Minocycline Treatment with Radiolabeled Annexin V in an Experimental Model of Focal Cerebral Ischemia J. Nucl. Med., November 1, 2007; 48(11): 1822 - 1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Paul, S. Strickland, and J. P. Melchor Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease J. Exp. Med., August 6, 2007; 204(8): 1999 - 2008. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |